Wikisage, the free encyclopedia of the second generation, is digital heritage
Epidiolex: Difference between revisions
Jump to navigation
Jump to search
(init) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
Epidiolex is a trademark of GW Pharmaceutics approved by FDA as orphan drug in the treatment of [[ | Epidiolex is a trademark of GW Pharmaceutics approved by FDA as orphan drug in the treatment of [[Dravet%27s_syndrome|Dravet-syndrome]]<ref>https://karmel.miraheze.org/wiki/CBD#ATC</ref><references/> | ||
Latest revision as of 14:03, 11 July 2018
Epidiolex is a trademark of GW Pharmaceutics approved by FDA as orphan drug in the treatment of Dravet-syndrome[1]